A major challenge in human genetics is the prioritization of causal genes in common complex diseases. A genome-wide CRISPR screen for intracellular insulin content in a human β-cell line has now identified a new candidate gene for type 2 diabetes, demonstrating the utility of this screening approach in β-cells.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Grotz, A. et al. Curr. Diab. Rep. 17, 76 (2017).
Barroso, I. & McCarthy, M. I. Cell 177, 146–161 (2019).
Rottner, A. K. et al. Nat. Genet. https://doi.org/10.1038/s41588-022-01261-2 (2022).
Ravassard, P. et al. J. Clin. Invest. 121, 3589–3597 (2011).
Udler, M. S. et al. PLoS Med. 15, e1002654 (2018).
Fang, Z. et al. Cell Rep. 26, 3132–3144 (2019).
Cai, E. P. et al. Nat. Metab. 2, 934–945 (2020).
Bevacqua, R. et al. Nat. Commun. 12, 2397 (2021).
Krentz, N. A. J. & Gloyn, A. L. Nat. Rev. Endocrinol. 16, 202–212 (2020).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wagner, B.K. Identifying type 2 diabetes risk genes by β-cell CRISPR screening. Nat Genet 55, 4–5 (2023). https://doi.org/10.1038/s41588-022-01269-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-022-01269-8
